| Financial Year |
March 31 2023 |
| Monetary Funds |
322,043,470.16 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
7,670,678.33 |
| Advances to Suppliers |
2,166,131.15 |
| Other Receivables |
1,143,063.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
21,675,920.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,373,559.09 |
| Total Current Assets |
356,072,823.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
489,362,939.25 |
| Investment Properties |
285,572,904.40 |
| Fixed Assetes |
38,823,546.35 |
| Under-construction Projects |
119,207.92 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
72,981,530.70 |
| R&D expenses |
-- |
| Goodwill |
1.00 |
| Long-Term Deferred and Prepaid Expenses |
3,922,243.10 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,245,155,242.26 |
| Total Assets |
1,601,228,065.46 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
3,262,199.52 |
| Accounts Received In Advance |
2,772,603.28 |
| Employee Compensation Payable |
-- |
| Taxes Payable |
799,339.25 |
| Interest Payable |
-- |
| Dividend Payable |
565,147.22 |
| Other payables |
12,319,036.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,616,888.52 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
59,416,991.59 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
298,571.22 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
53,550,618.71 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
74,780,351.22 |
| Total Liabilities |
134,197,342.81 |
| Paid-In Capital(Or Share Stock) |
400,881,981.00 |
| Capital Surplus |
183,685,739.04 |
| Surplus Reserve |
124,453,517.04 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
597,440,852.93 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,467,030,722.65 |
| Owner's Equity（Stockholder's Equity） |
1,467,030,722.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,601,228,065.46 |
